AB-1009 is an investigational gene therapy that has not been approved by any regulatory authority, and its efficacy and safety have not been established or fully evaluated. For more information, ...

Bayer has opened a new legal front in the long-running battles over COVID-19 vaccine technology, suing several major ...

Bayer has filed lawsuits in U.S. federal courts seeking a share of the revenue generated from COVID-19 vaccines sold by ...

This week it was announced that a provision denying people the right to sue chemical companies was dropped from FY2026 ...

Bayer has filed patent infringement lawsuits against COVID-19 vaccine makers Pfizer, BioNTech, Moderna, and Johnson & Johnson ...

Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court ​on Tuesday for ...

Bayer Crop Science’s seed production plants play a critical role in ensuring the performance farmers expect from DEKALB® corn and Asgrow® soybeans. In this Managing for Profit, Clint Rodenberg, ...

The Trump administration has diverged from the position of former US President Joe Biden, throwing its weight behind German chemical giant Bayer in its courtroom ...

Agriculture is full of nuance. What works in one region, crop, or season can be completely wrong in another. A weedkiller that’s effective in Nebraska might be restricted in Indiana. A fungicide that ...

Wondering if Bayer at €36.50 is a genuine turnaround value play or a classic value trap? This article will walk you through the numbers without the jargon. After years of lacklustre returns, the stock ...

Bayer made headlines this week after its stock went up 14.9 percent on Monday, reaching a near two-year high on the Frankfurt market, Reuters reported. The surge was the direct result of the Trump ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...